Connection

Patrick Flume to Respiratory System Agents

Back to Details
This is a "connection" page, showing publications Patrick Flume has written about Respiratory System Agents.
Patrick Flume
Connection Strength
0.121
Respiratory System Agents
  1. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial. Lancet Respir Med. 2015 Jul; 3(7):524-33.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.